Last $3.02 USD
Change Today +0.02 / 0.67%
Volume 64.4K
SURG On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ CM
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

synergetics usa inc (SURG) Snapshot

Open
$3.00
Previous Close
$3.00
Day High
$3.03
Day Low
$2.99
52 Week High
10/1/13 - $4.99
52 Week Low
03/26/14 - $2.93
Market Cap
76.5M
Average Volume 10 Days
149.8K
EPS TTM
$0.20
Shares Outstanding
25.3M
EX-Date
--
P/E TM
15.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNERGETICS USA INC (SURG)

Related News

No related news articles were found.

synergetics usa inc (SURG) Related Businessweek News

No Related Businessweek News Found

synergetics usa inc (SURG) Details

Synergetics USA, Inc., a medical device company, provides precision surgical devices primarily for the ophthalmology and neurosurgery markets in the United States and internationally. The company’s product lines focuses upon precision engineered disposable and reusable devices, surgical equipment, procedural kits, and the delivery of various energy modalities, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, and visible light energy for illumination. It offers approximately 650 catalogue items in the vitreoretinal surgical market, including vitrectomy system under the VersaVIT brand; procedural packs under the VersaPACK and Core Essentials brands; fiberoptic endoilluminators and endolaser probes; various disposable and reusable devices designed for intraocular manipulation of tissues; illumination equipment under the Photon brand; laser equipment under the Ellex’s Solitaire, Quantel’s Supra, and Vitra brands; Volk’s line of ophthalmic lenses; Labtician’s line of scleral buckles, and other miscellaneous products. The company sells its products directly, as well as through distributors and independent sales representatives to end-users at hospitals, ambulatory surgery centers, and surgeon offices. Synergetics USA, Inc. is headquartered in O’Fallon, Missouri.

335 Employees
Last Reported Date: 10/1/13

synergetics usa inc (SURG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $410.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $280.8K
Vice President of Marketing and Technology
Total Annual Compensation: $260.0K
Vice President of Domestic Sales
Total Annual Compensation: $222.5K
Consultant
Total Annual Compensation: $283.8K
Compensation as of Fiscal Year 2013.

synergetics usa inc (SURG) Key Developments

Synergetics USA, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended April 30, 2014

Synergetics USA, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended April 30, 2014. For the quarter, the company reported net sales of $16,135,000 compared to $16,264,000 a year ago. Operating income was $1,411,000 compared to $1,721,000 a year ago. Income from operations before provision for income taxes was $1,412,000 compared to $1,712,000 a year ago. Net income was $943,000 or $0.04 per basic and diluted share compared to $1,150,000 or $0.05 per basic and diluted share a year ago. The decrease in third quarter sales from last year was due primarily to lower Domestic ophthalmic sales. The company posted a solid improvement in cash flow from operations, which increased close to 25% year-over-year to $1.4 million. Earnings before interest, taxes, depreciation and amortization, or EBITDA, totaled $1.9 million this year compared to $2.2 million in the third quarter of fiscal 2013. For the nine months, the company reported net sales of $46,761,000 compared to $44,939,000 a year ago. Operating income was $2,426,000 compared to $1,509,000 a year ago. Income from operations before provision for income taxes was $2,433,000 compared to $1,486,000 a year ago. Net income was $1,652,000 or $0.07 per basic and diluted share compared to $1,120,000 or $0.04 per basic and diluted share a year ago. Net cash provided by operating activities was $1,437,000 compared to $1,158,000 a year ago. Purchase of property and equipment was $800,000 compared to $397,000 a year ago. Acquisition of patents and other intangibles was $229,000 compared to $298,000 a year ago. The change in cash flow from operations was largely the result of higher net income and the benefits from deferred income taxes offset by higher working capital balances compared to last year.

Synergetics USA, Inc. Announces Introduction of the VersaVIT 2.0 Vitrectomy System

Synergetics USA, Inc. announced the introduction of the VersaVIT 2.0 vitrectomy system. VersaVIT 2.0 is the market's first and only simplified, small form vitrectomy system providing creative solutions to help yield operational efficiencies for any operating room. Designed to provide a high level of sophistication simplistically, the system enables efficiencies for surgeons and patients. VersaVIT 2.0 offers an improvement over the first generation system by providing high speed cutting in combination with active duty cycle control. Combined, both high speed cutting and duty cycle control provide surgeons with a more efficient way to remove vitreous while simultaneously increasing safety by decreasing traction on retinal tissues when shaving along the base of the retina. Additional features of the VersaVIT 2.0 system and accessories include LED illumination, pressurized infusion and a silicone oil collection chamber.

Synergetics USA, Inc. to Report Q3, 2014 Results on Jun 09, 2014

Synergetics USA, Inc. announced that they will report Q3, 2014 results on Jun 09, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SURG:US $3.02 USD +0.02

SURG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bovie Medical Corp $3.82 USD 0.00
Ellex Medical Lasers Ltd A$0.35 AUD +0.015
Iridex Corp $7.97 USD +0.04
Stereotaxis Inc $3.34 USD +0.02
Vascular Solutions Inc $21.89 USD -0.41
View Industry Companies
 

Industry Analysis

SURG

Industry Average

Valuation SURG Industry Range
Price/Earnings 24.8x
Price/Sales 1.2x
Price/Book 1.2x
Price/Cash Flow 24.8x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGETICS USA INC, please visit www.synergeticsusa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.